Document is current

Any future updates will be listed below

MDM2 is an important prognostic and predictive factor for platin–pemetrexed therapy in malignant pleural mesotheliomas and deregulation of P14/ARF (encoded by CDKN2A) seems to contribute to an MDM2-driven inactivation of P53

Crossref DOI link: https://doi.org/10.1038/bjc.2015.27

Published Online: 2015-02-10

Published Print: 2015-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark